Lidinafree

Ketotifen, the active ingredient in Lidinafree, is an antihistamine (mast cell stabilizer) presented as an ophthalmic solution for ocular use. Approved in the European Union, it alleviates allergic conjunctivitis and associated ocular itching, redness, and tearing in patients experiencing eye allergy symptoms.

GNH USA supplies Lidinafree as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, transplant centres and clinics worldwide, providing reliable sourcing for regulated eye‑care products. All batches are manufactured under GMP conditions and undergo rigorous quality testing before release.

Ketotifen ophthalmic solution is used to manage allergic eye conditions by stabilizing mast cells and blocking histamine receptors. - Allergic conjunctivitis: reduces inflammation, itching, and redness in the conjunctiva. - Ocular itching due to allergy: relieves itching sensations in the eye caused by allergen exposure. - Redness of the eye due to allergy: diminishes vascular dilation and redness associated with allergic reactions.

Ketotifen ophthalmic solution may cause local ocular reactions and, rarely, systemic effects.

Common Side Effects: - Burning or stinging: mild transient sensation in the eye immediately after drop instillation, usually resolves within minutes. - Redness: slight conjunctival hyperemia that may appear shortly after dosing and subsides with continued use. - Blurred vision: temporary visual blur that typically clears within a few minutes after the drop.

Serious or Rare Side Effects: - Severe allergic reaction: signs of angioedema, swelling, or anaphylaxis requiring urgent medical attention. - Corneal ulceration: rare but serious corneal epithelial damage that can impair vision if not treated promptly. - Persistent eye irritation: prolonged discomfort, foreign body sensation, or inflammation that persists beyond normal adaptation and warrants evaluation.

When using Ketotifen ophthalmic solution, consider the following precautions to ensure safe and effective therapy. - Avoid contact lenses: do not wear soft contact lenses immediately after instillation; wait at least 15 minutes. - Monitor for hypersensitivity: discontinue use and seek medical advice if signs of allergic reaction appear. - Use as directed: follow the prescriber’s dosing schedule and do not exceed recommended frequency. - Caution in ocular surgery: inform the ophthalmologist if using the product before any eye procedures. - Pregnancy and lactation: discuss potential risks with a healthcare professional before use. - Store at room temperature: keep the bottle below 25 °C, protect from light and moisture, and retain the original packaging.

Ketotifen ophthalmic solution may interact with certain medications or substances; awareness of these interactions helps prevent reduced efficacy or increased adverse effects.

Major Interactions (Avoid): - Anticholinergic eye drops: may increase ocular dryness and discomfort. - Other mast cell stabilizers: concurrent use may not provide additional benefit and could increase irritation.

Moderate Interactions (Monitor Closely): - Systemic antihistamines: may potentiate sedation if systemic absorption occurs. - Non‑steroidal anti‑inflammatory eye drops: monitor for additive irritation. - Topical ocular steroids: assess for combined effects on intra‑ocular pressure.